«SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY. Medicine 2022, 3 (2), 38-42. https://doi.org/10.26577/IAM.2022.v3.i2.08.